Summary by Futu AI
On May 20, 2024, Johnson & Johnson successfully completed a series of public offerings, raising a significant amount of capital through the issuance of various notes. The offerings included $1,150,000,000 of 4.800% Notes due in 2029, $1,150,000,000 of 4.900% Notes due in 2031, $850,000,000 of 4.950% Notes due in 2034, and $850,000,000 of 5.250% Notes due in 2054, collectively known as the U.S. Dollar Notes. Additionally, the company offered Euro Notes, comprising €700,000,000 of 3.200% Notes due in 2032, €800,000,000 of 3.350% Notes due in 2036, and €1,000,000,000 of 3.550% Notes due in 2044. These offerings were made under Johnson & Johnson's Registration Statement on Form S-3. The company entered into underwriting agreements with major financial institutions, including J.P. Morgan Securities LLC, BofA Securities, Inc., Citigroup Global Markets Inc., and others for the U.S. Dollar Notes, and with J.P. Morgan Securities plc, Citigroup Global Markets Limited, Deutsche Bank AG, London Branch, and others for the Euro Notes.